technetium tc 99m sestamibi has been researched along with metoprolol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bech, J; Hvid-Jacobsen, K; Kelbaek, H; Madsen, JK; Skagen, K | 1 |
Adachi, H; Hoshizaki, H; Isobe, N; Naito, S; Oshima, S; Seki, R; Taniguchi, K; Toyama, T | 1 |
Ahlberg, AW; Heller, GV; Lamargese, I; Masood, Y; Mather, JF; McGill, CC; Taillefer, R; White, CM | 1 |
Gerson, MC | 1 |
4 trial(s) available for technetium tc 99m sestamibi and metoprolol
Article | Year |
---|---|
Metoprolol abolishes exercise-induced left ventricular dysfunction in patients with silent ischemia.
Topics: Adrenergic beta-Antagonists; Cross-Over Studies; Double-Blind Method; Electrocardiography; Exercise; Exercise Test; Female; Gated Blood-Pool Imaging; Humans; Male; Metoprolol; Middle Aged; Myocardial Ischemia; Stroke Volume; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left; Ventricular Function, Left | 1996 |
Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
Topics: 3-Iodobenzylguanidine; Adrenergic Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Dipyridamole; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2003 |
Reduction in dipyridamole-induced single-photon emission computed tomography myocardial defect size by beta-blockers: time to re-examine the patient preparation protocol for pharmacologic stress testing.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Dipyridamole; Double-Blind Method; Exercise Test; Humans; Metoprolol; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2003 |